Comparative effectiveness and safety of rivaroxaban in adults with nonvalvular atrial fibrillation
WS Aronow, TA Shamliyan - American Journal of Therapeutics, 2019 - journals.lww.com
Background: All evidence regarding benefits and harms of rivaroxaban for stroke prevention
has not been appraised yet. Study Question: What are the comparative effectiveness and …
has not been appraised yet. Study Question: What are the comparative effectiveness and …
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Background The use of warfarin reduces the rate of ischemic stroke in patients with atrial
fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor …
fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor …
[HTML][HTML] Assessing the Safety and Efficacy of Rivaroxaban for Stroke Prevention in Patients With Atrial Fibrillation: A Systemic Review and Meta-Analysis
GS Virk, S Javed, R Chaudhry, MM Moazam… - Cureus, 2024 - ncbi.nlm.nih.gov
An effective anticoagulation therapy is required for patients with atrial fibrillation because it
presents a significant risk of stroke. The current study evaluates the relative safety as well as …
presents a significant risk of stroke. The current study evaluates the relative safety as well as …
Effectiveness and safety of different rivaroxaban dosage regimens in patients with non-valvular atrial fibrillation: a nationwide, population-based cohort study
The objective of this study is to evaluate the effectiveness of different rivaroxaban dosage
regimens in preventing ischemic stroke and systemic thromboembolism among Asians. A …
regimens in preventing ischemic stroke and systemic thromboembolism among Asians. A …
[HTML][HTML] Efficacy and Safety of Different Dosing Regimens of Rivaroxaban in Patients With Atrial Fibrillation for Stroke Prevention: A Systematic Review and Meta …
A Popat, SK Patel, S Adusumilli, A Irshad, A Nagaraj… - Cureus, 2024 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) poses a substantial risk of stroke, necessitating effective
anticoagulation therapy. This systematic review and meta-analysis (SRMA) evaluates the …
anticoagulation therapy. This systematic review and meta-analysis (SRMA) evaluates the …
Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF
AS Barnett, DD Cyr, SG Goodman, BS Levitan… - International journal of …, 2018 - Elsevier
Aims The aim of this study was to determine the net clinical benefit (NCB) of rivaroxaban
compared with warfarin in patients with atrial fibrillation. Methods This was a retrospective …
compared with warfarin in patients with atrial fibrillation. Methods This was a retrospective …
Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice
G Barón-Esquivias, F Marín… - Expert Review of …, 2017 - Taylor & Francis
Introduction: Registries and non-interventional studies offer relevant and complementary
information to clinical trials, since they have a high external validity. Areas covered: The …
information to clinical trials, since they have a high external validity. Areas covered: The …
Understanding the value of real-world evidence: focus on stroke prevention in atrial fibrillation with rivaroxaban
AJ Camm, CI Coleman, TB Larsen… - Thrombosis and …, 2018 - thieme-connect.com
Real-world data are a well-recognized component within the drug lifecycle, and such data
are generated from a range of sources and study designs, including claims databases …
are generated from a range of sources and study designs, including claims databases …
Rivaroxaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: clinical implications of the ROCKET AF trial and its …
RJ Spencer, JV Amerena - American Journal of Cardiovascular Drugs, 2015 - Springer
Atrial fibrillation (AF) is an increasingly common cause of stroke and systemic embolism.
While warfarin has been the mainstay of stroke prevention in patients with AF, newer novel …
While warfarin has been the mainstay of stroke prevention in patients with AF, newer novel …
Effectiveness and safety of rivaroxaban in nonvalvular atrial fibrillation: data from a contemporary Spanish registry
C Caro Martinez, JJ Cerezo Manchado… - Current Medical …, 2019 - Taylor & Francis
Objective: To ascertain the clinical profile, management and rates of thromboembolic and
bleeding complications in a contemporary cohort of patients with nonvalvular atrial …
bleeding complications in a contemporary cohort of patients with nonvalvular atrial …
相关搜索
- atrial fibrillation stroke prevention
- atrial fibrillation rivaroxaban in patients
- atrial fibrillation meta analysis
- atrial fibrillation safety and efficacy
- efficacy and safety rivaroxaban in patients
- dosage regimens effectiveness and safety
- atrial fibrillation dosing regimens
- atrial fibrillation everyday practice
- atrial fibrillation efficacy of rivaroxaban